iRadimed
IRMD
139 hedge funds and large institutions have $300M invested in iRadimed in 2024 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 66 increasing their positions, 33 reducing their positions, and 16 closing their positions.
7,475% more call options, than puts
Call options by funds: $303K | Put options by funds: $4K
100% more repeat investments, than reductions
Existing positions increased: 66 | Existing positions reduced: 33
81% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 16
9% more funds holding
Funds holding: 127 → 139 (+12)
1% more capital invested
Capital invested by funds: $295M → $300M (+$4.35M)
0.84% more ownership
Funds ownership: 53.05% → 53.89% (+0.84%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$6.79M |
| 2 |
NTCM
Nine Ten Capital Management
Chicago,
Illinois
|
+$2.91M |
| 3 |
LIP
Liontrust Investment Partners
London,
United Kingdom
|
+$2.74M |
| 4 |
Goldman Sachs
New York
|
+$1.94M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.81M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$11M |
| 2 |
RCMC
RK Capital Management (Colorado)
Denver,
Colorado
|
-$5.49M |
| 3 |
HIM
Hillsdale Investment Management
Toronto,
Ontario, Canada
|
-$4.28M |
| 4 |
RC
Roubaix Capital
Denver,
Colorado
|
-$2.21M |
| 5 |
Fiera Capital (Canada)
Montreal,
Quebec, Canada
|
-$1.26M |
IRMD Hedge Fund Activity: Q2 2024 in Review
139 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in iRadimed (IRMD) for Q2 2024, worth a combined $300M — up 1.5% from $295M a quarter earlier.
Buyers outnumbered sellers: 29 funds opened new IRMD positions and 16 closed out — a net gain of 13 holders — while 66 added to existing stakes and 33 trimmed.
The largest buyer was BlackRock, adding an estimated $6.79M. The largest seller was Soleus Capital Management, cutting an estimated $11M.
- 139 institutional investors held iRadimed (IRMD) as of Q2 2024, up from 127 in Q1 2024.
- Funds reported $300M of iRadimed stock for Q2 2024, up 1.5% quarter-over-quarter.
- 29 funds opened new iRadimed positions in Q2 2024 and 16 closed out, a net change of +13 holders.
- The largest iRadimed buyer in Q2 2024 was BlackRock, an estimated $6.79M added.
- The largest iRadimed seller in Q2 2024 was Soleus Capital Management, an estimated $11M sold.
Based on aggregated 13F filings for Q2 2024.